Bob Daber

Bob Daber is an experienced BioTech executive with a passion for technology innovation and implementation. With over 6 years of expertise in developing and managing high-complexity genomic diagnostic laboratories, Bob has worked both in academia and industry, significantly contributing to the field of clinical genomics. Bob co-founded Genosity, where they served as President and Chief Technology Officer before the company was acquired by Invitae. Currently, Bob is the Vice President of Science and Technology Development at Labcorp, and previously led consulting services at Gnosity Consults, LLC, focusing on genomic R&D and laboratory optimization. Bob holds a Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania, alongside a B.S. in Biochemistry and Applied Molecular Biology.